MicroRNA expression in abdominal and gluteal adipose tissue is associated with mRNA expression levels and partly genetically driven.
- Authors
- Rantalainen, Mattias; Herrera, Blanca M; Nicholson, George; Bowden, Rory; Wills, Quin F; Min, Josine L; Neville, Matt J; Barrett, Amy; Allen, Maxine; Rayner, Nigel W; Fleckner, Jan; McCarthy, Mark I; Zondervan, Krina T; Karpe, Fredrik; Holmes, Chris C; Lindgren, Cecilia M
- Year
- 2011
- Journal
- PloS one
- PMID
- 22102887
- DOI
- 10.1371/journal.pone.0027338
- PMCID
- PMC3216936
To understand how miRNAs contribute to the molecular phenotype of adipose tissues and related traits, we performed global miRNA expression profiling in subcutaneous abdominal and gluteal adipose tissue of 70 human subjects and characterised which miRNAs were differentially expressed between these tissues. We found that 12% of the miRNAs were significantly differentially expressed between abdominal and gluteal adipose tissue (FDR adjusted p<0.05) in the primary study, of which 59 replicated in a follow-up study of 40 additional subjects. Further, 14 miRNAs were found to be associated with metabolic syndrome case-control status in abdominal tissue and three of these replicated (primary study: FDR adjusted p<0.05, replication: p<0.05 and directionally consistent effect). Genome-wide genotyping was performed in the 70 subjects to enable miRNA expression quantitative trait loci (eQTL) analysis. Candidate miRNA eQTLs were followed-up in the additional 40 subjects and six significant, independent cis-located miRNA eQTLs (primary study: p<0.001; replication: p<0.05 and directionally consistent effect) were identified. Finally, global mRNA expression profiling was performed in both tissues to enable association analysis between miRNA and target mRNA expression levels. We find 22% miRNAs in abdominal and 9% miRNAs in gluteal adipose tissue with expression levels significantly associated with the expression of corresponding target mRNAs (FDR adjusted p<0.05). Taken together, our results indicate a clear difference in the miRNA molecular phenotypic profile of abdominal and gluteal adipose tissue, that the expressions of some miRNAs are influenced by cis-located genetic variants and that miRNAs are associated with expression levels of their predicted mRNA targets.
Tissue differential expression (the tissue-related fixed-effects coefficients (β)), of the 59 miRNA that were replicated (p-value<0.05) in the replication study.The coefficients (β) are sorted on effect-size, a positive value indicating higher expression in gluteal adipose tissue relative abdominal adipose tissue. Error-bars show the standard-error of β for each miRNA.
Locus plots for miRNA eQTLs that replicated.P-values from the primary study are shown in figure (criteria for replication: p-value<0.001 in the primary study and p-value<0.05 in the replication study with a directionally consistent effect). A) Abdominal adipose tissue hsa-miR-1255a:rs1822168 (p-value = 1.83E-05 in primary study and p-value = 9.91E-03 in replication study) B) Abdominal adipose tissue hsa-miR-618: rs1716543 (p-value = 5.34E-04 in primary study and p-value = 5.80E-03 in replication study) C) Abdominal adipose tissue hsa-miR-146a*:rs2961920 (p-value = 5.87E-04e in primary study and p-value = 6.45E-06 in replication study) D) Gluteal adipose tissue hsa-miR-1255a:rs1822168 (p-value = 1.56E-05 in primary study and p-value = 1.65E-04 in replication study), E) Gluteal adipose tissue hsa-miR-1307:rs11191666 (p-value = 1.27E-04 in primary study and p-value = 3.55E-04 in replication study), F) Gluteal adipose tissue hsa-miR-330-3p:rs7252175 (p-value = 3.85E-04 in primary study and p-value = 4.04E-02 in replication study).
Genetic effects in replicated miRNA eQTLs in abdominal adipose tissue (see Materials and Methods section for criteria).The violin-plot represents the density of miRNA expression relating to the SNP effect for each genotype (variability relating to the other fixed effects was regressed out); the line represents the fixed-effect coefficient (β) relating to the SNP effect. A) Primary study hsa-miR-1255a:rs1822168 B) Primary study hsa-miR-618:rs1716543 C) Primary study hsa-miR-146a*:rs2961920 D) Replication study hsa-miR-1255a:rs1822168 E) Replication study hsa-miR-618:rs1716543. F) Replication study hsa-miR-146a*:rs2961920.
Genetic effects in replicated miRNA eQTLs in gluteal adipose tissue (see Materials and Methods section for criteria).The violin-plot represents the density of miRNA expression relating to the SNP effect for each genotype (variability relating to other fixed effects was regressed out); the line represents the fixed-effect coefficient (β) relating to the SNP effect. A) Primary study hsa-miR-1255a:rs1822168 B) Primary study hsa-miR-1307:rs11191666. C) Primary study hsa-miR-330-3p:rs7252175 D) Replication study hsa-miR-1255a:rs1822168. E) Follow up study hsa-miR-1307:rs11191666. F) Replication study hsa-miR-330-3p:rs7252175.
| Name | Type |
|---|---|
| 40 subjects local | cohort |
| 70 human subjects local | cohort |
| abdominal adipose local | cohort |
| Abdominal adipose local | cohort |
| abdominal adipose cohort local | cohort |
| abdominal adipose tissue local | cohort |
| abdominal adipose tissue local | drug |
| abdominal adipose tissue | phenotype |
| abdominal tissue local | anatomy |
| Abdominal tissue local | drug |
| ACVR2B local | gene |
| adipocyte differentiation | phenotype |
| Adipocytokine signalling pathway local | drug |
| adipose tissue | phenotype |
| adipose tissue depots local | phenotype |
| adipose tissue development local | phenotype |
| adipose tissue distribution local | phenotype |
| adiposity | phenotype |
| adverse metabolic outcomes local | phenotype |
| adverse metabolic risk local | phenotype |
| Affymetrix GeneChip HGU133 Plus 2.0 array local | drug |
| Affymetrix human GeneChip HGU133 Plus 2.0 array local | drug |
| age | phenotype |
| android fat distribution local | phenotype |
| Batch (96-well plate) local | drug |
| blood pressure | phenotype |
| BMI | phenotype |
| body mass index | phenotype |
| case-control status local | cohort |
| case group | cohort |
| cis-located genetic variants local | variant |
| cis miRNA eQTL local | variant |
| cis-SNPs local | variant |
| common variants | cohort |
| control group | cohort |
| custom chip-definition files (CDFs) local | drug |
| dyslipidaemia local | phenotype |
| Ensembl-annotated gene local | gene |
| Fasting glucose level local | phenotype |
| fat distribution | phenotype |
| GeneCatcher™ local | drug |
| general metabolic deregulation local | phenotype |
| genetic variants | cohort |
| GenomeStudio version 1.6.0 local | drug |
| Genotype detection local | phenotype |
| GIANT consortium | cohort |
| gluteal adipose local | cohort |
| Gluteal adipose local | cohort |
| gluteal adipose cohort local | cohort |
| gluteal adipose tissue local | cohort |
| gluteal adipose tissue local | drug |
| gluteal adipose tissue local | phenotype |
| gluteal tissue local | anatomy |
| Gluteal tissue local | drug |
| gynoid fat distribution local | phenotype |
| HC | cohort |
| healthy controls | cohort |
| High-density lipoprotein level local | phenotype |
| hsa-miR-10a local | drug |
| hsa-miR-10b local | drug |
| hsa-miR-1179 local | drug |
| hsa-miR-1255a local | drug |
| hsa-miR-128 local | gene |
| hsa-miR-141 local | gene |
| hsa-miR-181a local | gene |
| hsa-miR-183 local | gene |
| hsa-miR-186 local | gene |
| hsa-miR-195 local | drug |
| hsa-miR-196b local | gene |
| hsa-miR-199a-5p local | drug |
| hsa-miR-204 local | drug |
| hsa-miR-211 local | drug |
| hsa-miR-27b local | drug |
| hsa-miR-27b local | gene |
| hsa-miR-28-5p local | drug |
| hsa-miR-28-5p local | gene |
| hsa-miR-30a local | gene |
| hsa-miR-30d local | gene |
| hsa-miR-326 local | drug |
| hsa-miR-326 local | gene |
| hsa-miR-331-3p local | drug |
| hsa-miR-335* local | drug |
| hsa-miR-340 local | gene |
| hsa-miR-34a local | drug |
| hsa-miR-365 local | drug |
| hsa-miR-503 local | drug |
| hsa-miR-519d local | drug |
| hsa-miR-519d local | gene |
| hsa-miR-520c-3p local | gene |
| hsa-miR-520f local | gene |
| hsa-miR-590-3p local | gene |
| hsa-miR-652 local | drug |
| hsa-miR-7-2* local | drug |
| hsa-miR-7-2* local | gene |
| human fibroblasts | cohort |
| human fibroblasts local | drug |
| hypertension | phenotype |
| IDF criteria local | phenotype |
| Illumina 317 k Beadchip platform local | drug |
| Illumina 317k Beadchip platform local | drug |
| Illumina BeadArray scanner local | drug |
| Illumina miRNA BeadArray platform local | drug |
| increased morbidity local | phenotype |
| INS | gene |
| Insulin signaling pathway local | drug |
| International Diabetes Foundation criteria local | phenotype |
| Isl1 | gene |
| KEGG terms local | drug |
| KEGG terms local | phenotype |
| MAPK signaling pathway | drug |
| MassARRAY platform local | drug |
| metabolic disorders | phenotype |
| metabolic dysregulation local | phenotype |
| metabolic syndrome | phenotype |
| Metabolic syndrome case local | phenotype |
| Metabolic syndrome case-control cohort local | cohort |
| metabolic syndrome case group local | cohort |
| metabolic syndrome cases local | cohort |
| Metabolic syndrome control local | phenotype |
| metabolic syndrome group local | cohort |
| metabolism | phenotype |
| miRNA | drug |
| miRNA local | gene |
| miRNA eQTL local | variant |
| miRNA eQTL SNP local | variant |
| miRNA expression local | drug |
| miRNA expression | phenotype |
| MolOBB study local | cohort |
| mRNA | drug |
| obesity | phenotype |
| obesity-related phenotype | phenotype |
| Oxford Biobank local | cohort |
| primary study local | cohort |
| Primary study local | cohort |
| Primary Study local | cohort |
| PSKH1 local | gene |
| RMA method local | drug |
| RNA | drug |
| rodent models of T2D local | cohort |
| Sequenom iPLEX assay local | drug |
| severe disease local | phenotype |
| sex | phenotype |
| SNP | cohort |
| SNP variant local | variant |
| study cohort | cohort |
| Study samples local | cohort |
| target mRNA local | gene |
| tissue | anatomy |
| tissue development local | phenotype |
| triglyceride levels | phenotype |
| TRIreagent local | drug |
| TRI Reagent local | drug |
| type 2 diabetes | phenotype |
| Type II diabetes mellitus local | phenotype |
| Universal-12 Illumina BeadChip local | drug |
| waist circumference | phenotype |
| waist hip ratio corrected for BMI local | phenotype |
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. | 2014 | 25231870 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A new approach to quantify visceral fat via bioelectrical impedance analysis and ultrasound compared to MRI. | Hoffmann J et al. | — | 2024 | → |
| Effect of miR-149-5p on intramuscular fat deposition in pigs based on metabolomics and transcriptomics | Liu Y et al. | — | 2023 | — |
| Effect of miR-149-5p on intramuscular fat deposition in pigs based on metabolomics and transcriptomics. | Liu Y et al. | — | 2023 | → |
| Changes in subcutaneous adipose tissue microRNA expression in response to exercise training in obese African women. | Pheiffer C et al. | — | 2022 | → |
| Ethnic and Adipose Depot Specific Associations Between DNA Methylation and Metabolic Risk. | Pheiffer C et al. | — | 2020 | → |
| MicroRNA Profiling in Adipose Before and After Weight Loss Highlights the Role of miR-223-3p and the NLRP3 Inflammasome. | Macartney-Coxson D et al. | — | 2020 | → |
| Population variation in miRNAs and isomiRs and their impact on human immunity to infection. | Rotival M et al. | — | 2020 | → |
| Identification of Metabolically Distinct Adipocyte Progenitor Cells in Human Adipose Tissues. | Raajendiran A et al. | — | 2019 | → |
| MicroRNA-196a links human body fat distribution to adipose tissue extracellular matrix composition. | Hilton C et al. | — | 2019 | → |
| MicroRNAs and regulation of cardiometabolic phenotypes: novel insights into the complexity of genome-wide association studies loci. | Civelek M et al. | — | 2019 | → |
| MicroRNAs as regulators of mitochondrial dysfunction and obesity. | Murri M et al. | — | 2018 | → |
| Potential role of microRNAs in the regulation of adipocytes liposecretion and adipose tissue physiology. | Maurizi G et al. | — | 2018 | → |
| A note on statistical repeatability and study design for high-throughput assays. | Nicholson G et al. | — | 2017 | → |
| Cellular Mechanisms Driving Sex Differences in Adipose Tissue Biology and Body Shape in Humans and Mouse Models. | Karastergiou K et al. | — | 2017 | → |
| MicroRNA-196 Regulates HOX Gene Expression in Human Gluteal Adipose Tissue. | Divoux A et al. | — | 2017 | → |
| Sexual dimorphisms in genetic loci linked to body fat distribution. | Pulit SL et al. | — | 2017 | → |
| Biology of upper-body and lower-body adipose tissue--link to whole-body phenotypes. | Karpe F et al. | — | 2015 | → |
| Genome-wide enrichment analysis between endometriosis and obesity-related traits reveals novel susceptibility loci. | Rahmioglu N et al. | — | 2015 | → |
| MicroRNA regulatory networks in human adipose tissue and obesity. | Arner P et al. | — | 2015 | → |
| A genomic portrait of the genetic architecture and regulatory impact of microRNA expression in response to infection. | Siddle KJ et al. | — | 2014 | → |
| Decrease of circulating SAA is correlated with reduction of abdominal SAA secretion during weight loss. | Yang RZ et al. | — | 2014 | → |
| Effects of long-term averaging of quantitative blood pressure traits on the detection of genetic associations. | Ganesh SK et al. | — | 2014 | → |
| Expression of inflammation-related genes in gluteal and abdominal subcutaneous adipose tissue during weight-reducing dietary intervention in obese women. | Mališová L et al. | — | 2014 | → |
| Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci. | Tragante V et al. | — | 2014 | → |
| Incorporating inter-relationships between different levels of genomic data into cancer clinical outcome prediction. | Kim D et al. | — | 2014 | → |
| MicroRNA-378 regulates adiponectin expression in adipose tissue: a new plausible mechanism. | Ishida M et al. | — | 2014 | → |
| miRNome of Italian Large White pig subcutaneous fat tissue: new miRNAs, isomiRs and moRNAs. | Gaffo E et al. | — | 2014 | → |
| Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. | Perry JR et al. | — | 2014 | → |
| Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins. | Postmus I et al. | — | 2014 | → |
| Synthesis of 53 tissue and cell line expression QTL datasets reveals master eQTLs. | Zhang X et al. | — | 2014 | → |
| Distinct developmental signatures of human abdominal and gluteal subcutaneous adipose tissue depots. | Karastergiou K et al. | — | 2013 | → |
| Epigenetic regulation of depot-specific gene expression in adipose tissue. | Gehrke S et al. | — | 2013 | → |
| Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits. | Civelek M et al. | — | 2013 | → |
| Global properties and functional complexity of human gene regulatory variation. | Gaffney DJ | — | 2013 | → |
| MicroRNAs in adipose tissue: their role in adipogenesis and obesity. | Hilton C et al. | — | 2013 | → |
| Relative impact of multi-layered genomic data on gene expression phenotypes in serous ovarian tumors. | Sohn KA et al. | — | 2013 | → |
| Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. | Randall JC et al. | — | 2013 | → |
| Extent, causes, and consequences of small RNA expression variation in human adipose tissue. | Parts L et al. | — | 2012 | → |
| Sex differences in human adipose tissues - the biology of pear shape. | Karastergiou K et al. | — | 2012 | → |